<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1992-05-01" modified="2020-10-07" version="228">
<accession>P25490</accession>
<accession>Q14935</accession>
<name>TYY1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Transcriptional repressor protein YY1</fullName>
</recommendedName>
<alternativeName>
<fullName>Delta transcription factor</fullName>
</alternativeName>
<alternativeName>
<fullName>INO80 complex subunit S</fullName>
</alternativeName>
<alternativeName>
<fullName>NF-E1</fullName>
</alternativeName>
<alternativeName>
<fullName>Yin and yang 1</fullName>
<shortName>YY-1</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">YY1</name>
<name type="synonym">INO80S</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Cell" volume="67" first="377" last="388">
<title>Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein.</title>
<authorList>
<person name="Shi Y."/>
<person name="Seto E."/>
<person name="Chang L.-S."/>
<person name="Shenk T."/>
</authorList>
<dbReference type="PubMed" id="1655281"/>
<dbReference type="DOI" id="10.1016/0092-8674(91)90189-6"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1991" name="Proc. Natl. Acad. Sci. U.S.A." volume="88" first="9804" last="9808">
<title>Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.</title>
<authorList>
<person name="Park K."/>
<person name="Atchison M."/>
</authorList>
<dbReference type="PubMed" id="1946405"/>
<dbReference type="DOI" id="10.1073/pnas.88.21.9804"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Foreskin</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="1992-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Whitson R.H."/>
<person name="Huang T."/>
<person name="Dang J."/>
<person name="Itakura K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
<tissue>Lymph</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1998" name="J. Cell. Biochem." volume="68" first="500" last="510">
<title>Targeting of the YY1 transcription factor to the nucleolus and the nuclear matrix in situ: the C-terminus is a principal determinant for nuclear trafficking.</title>
<authorList>
<person name="McNeil S."/>
<person name="Guo B."/>
<person name="Stein J.L."/>
<person name="Lian J.B."/>
<person name="Bushmeyer S."/>
<person name="Seto E."/>
<person name="Atchison M.L."/>
<person name="Penman S."/>
<person name="van Wijnen A.J."/>
<person name="Stein G.S."/>
</authorList>
<dbReference type="PubMed" id="9493912"/>
<dbReference type="DOI" id="10.1002/(sici)1097-4644(19980315)68:4&lt;500::aid-jcb9&gt;3.0.co;2-u"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1997" name="Nucleic Acids Res." volume="25" first="843" last="849">
<title>Yeast two-hybrid cloning of a novel zinc finger protein that interacts with the multifunctional transcription factor YY1.</title>
<authorList>
<person name="Kalenik J.L."/>
<person name="Chen D."/>
<person name="Bradley M.E."/>
<person name="Chen S.-J."/>
<person name="Lee T.-C."/>
</authorList>
<dbReference type="PubMed" id="9016636"/>
<dbReference type="DOI" id="10.1093/nar/25.4.843"/>
</citation>
<scope>INTERACTION WITH YAF2</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="Biochem. Biophys. Res. Commun." volume="285" first="27" last="31">
<title>Poly(ADP-ribosyl)ation of transcription factor Yin Yang 1 under conditions of DNA damage.</title>
<authorList>
<person name="Oei S.L."/>
<person name="Shi Y."/>
</authorList>
<dbReference type="PubMed" id="11437367"/>
<dbReference type="DOI" id="10.1006/bbrc.2001.5115"/>
</citation>
<scope>POLY-ADP-RIBOSYLATION BY PARP1</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="1360" last="1369">
<title>The polycomb group protein EED interacts with YY1, and both proteins induce neural tissue in Xenopus embryos.</title>
<authorList>
<person name="Satijn D.P.E."/>
<person name="Hamer K.M."/>
<person name="den Blaauwen J."/>
<person name="Otte A.P."/>
</authorList>
<dbReference type="PubMed" id="11158321"/>
<dbReference type="DOI" id="10.1128/mcb.21.4.1360-1369.2001"/>
</citation>
<scope>INTERACTION WITH EZH2 AND EZH2</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Development" volume="131" first="4709" last="4723">
<title>SMAD-mediated modulation of YY1 activity regulates the BMP response and cardiac-specific expression of a GATA4/5/6-dependent chick Nkx2.5 enhancer.</title>
<authorList>
<person name="Lee K.H."/>
<person name="Evans S."/>
<person name="Ruan T.Y."/>
<person name="Lassar A.B."/>
</authorList>
<dbReference type="PubMed" id="15329343"/>
<dbReference type="DOI" id="10.1242/dev.01344"/>
</citation>
<scope>DNA-BINDING</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH SMAD1 AND SMAD4</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2006" name="Oncogene" volume="25" first="1125" last="1142">
<title>Transcription factor YY1: structure, function, and therapeutic implications in cancer biology.</title>
<authorList>
<person name="Gordon S."/>
<person name="Akopyan G."/>
<person name="Garban H."/>
<person name="Bonavida B."/>
</authorList>
<dbReference type="PubMed" id="16314846"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209080"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2007" name="Nat. Struct. Mol. Biol." volume="14" first="872" last="874">
<title>YY1 functions with INO80 to activate transcription.</title>
<authorList>
<person name="Cai Y."/>
<person name="Jin J."/>
<person name="Yao T."/>
<person name="Gottschalk A.J."/>
<person name="Swanson S.K."/>
<person name="Wu S."/>
<person name="Shi Y."/>
<person name="Washburn M.P."/>
<person name="Florens L."/>
<person name="Conaway R.C."/>
<person name="Conaway J.W."/>
</authorList>
<dbReference type="PubMed" id="17721549"/>
<dbReference type="DOI" id="10.1038/nsmb1276"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN THE INO80 COMPLEX</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2007" name="Nat. Struct. Mol. Biol." volume="14" first="1165" last="1172">
<title>A YY1-INO80 complex regulates genomic stability through homologous recombination-based repair.</title>
<authorList>
<person name="Wu S."/>
<person name="Shi Y."/>
<person name="Mulligan P."/>
<person name="Gay F."/>
<person name="Landry J."/>
<person name="Liu H."/>
<person name="Lu J."/>
<person name="Qi H.H."/>
<person name="Wang W."/>
<person name="Nickoloff J.A."/>
<person name="Wu C."/>
<person name="Shi Y."/>
</authorList>
<dbReference type="PubMed" id="18026119"/>
<dbReference type="DOI" id="10.1038/nsmb1332"/>
</citation>
<scope>FUNCTION IN DNA REPAIR</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DNA-BINDING</scope>
<scope>PROTEIN INTERACTION</scope>
<scope>IDENTIFICATION IN THE INO80 COMPLEX</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-247</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="909" last="917">
<title>Distinct modes of regulation of the Uch37 deubiquitinating enzyme in the proteasome and in the Ino80 chromatin-remodeling complex.</title>
<authorList>
<person name="Yao T."/>
<person name="Song L."/>
<person name="Jin J."/>
<person name="Cai Y."/>
<person name="Takahashi H."/>
<person name="Swanson S.K."/>
<person name="Washburn M.P."/>
<person name="Florens L."/>
<person name="Conaway R.C."/>
<person name="Cohen R.E."/>
<person name="Conaway J.W."/>
</authorList>
<dbReference type="PubMed" id="18922472"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.08.027"/>
</citation>
<scope>IDENTIFICATION IN THE INO80 COMPLEX</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-247 AND THR-378</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="Genomics" volume="93" first="152" last="158">
<title>YY1's longer DNA-binding motifs.</title>
<authorList>
<person name="Kim J."/>
<person name="Kim J."/>
</authorList>
<dbReference type="PubMed" id="18950698"/>
<dbReference type="DOI" id="10.1016/j.ygeno.2008.09.013"/>
</citation>
<scope>DNA-BINDING MOTIF</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-118 AND SER-247</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="PLoS ONE" volume="5" first="E11332" last="E11332">
<title>Development and validation of a method for profiling post-translational modification activities using protein microarrays.</title>
<authorList>
<person name="Del Rincon S.V."/>
<person name="Rogers J."/>
<person name="Widschwendter M."/>
<person name="Sun D."/>
<person name="Sieburg H.B."/>
<person name="Spruck C."/>
</authorList>
<dbReference type="PubMed" id="20596523"/>
<dbReference type="DOI" id="10.1371/journal.pone.0011332"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-118</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="11283" last="11289">
<title>Subunit organization of the human INO80 chromatin remodeling complex: An evolutionarily conserved core complex catalyzes ATP-dependent nucleosome remodeling.</title>
<authorList>
<person name="Chen L."/>
<person name="Cai Y."/>
<person name="Jin J."/>
<person name="Florens L."/>
<person name="Swanson S.K."/>
<person name="Washburn M.P."/>
<person name="Conaway J.W."/>
<person name="Conaway R.C."/>
</authorList>
<dbReference type="PubMed" id="21303910"/>
<dbReference type="DOI" id="10.1074/jbc.m111.222505"/>
</citation>
<scope>IDENTIFICATION IN THE INO80 COMPLEX</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-118</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2013" name="J. Biosci." volume="38" first="105" last="112">
<title>Regulation of DU145 prostate cancer cell growth by Scm-like with four mbt domains 2.</title>
<authorList>
<person name="Lee K."/>
<person name="Na W."/>
<person name="Maeng J.H."/>
<person name="Wu H."/>
<person name="Ju B.G."/>
</authorList>
<dbReference type="PubMed" id="23385818"/>
<dbReference type="DOI" id="10.1007/s12038-012-9283-6"/>
</citation>
<scope>INTERACTION WITH SFMBT2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-118; SER-187 AND SER-247</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-118 AND SER-247</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-183; LYS-286 AND LYS-288</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-288</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-288</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-182; LYS-183; LYS-208; LYS-230; LYS-286; LYS-288; LYS-409 AND LYS-411</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1996" name="Proc. Natl. Acad. Sci. U.S.A." volume="93" first="13577" last="13582">
<title>Cocrystal structure of YY1 bound to the adeno-associated virus P5 initiator.</title>
<authorList>
<person name="Houbaviy H.B."/>
<person name="Usheva A."/>
<person name="Shenk T."/>
<person name="Burley S.K."/>
</authorList>
<dbReference type="PubMed" id="8942976"/>
<dbReference type="DOI" id="10.1073/pnas.93.24.13577"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 304-414</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1998" name="J. Mol. Biol." volume="279" first="973" last="986">
<title>Design, synthesis and structure of a zinc finger with an artificial beta-turn.</title>
<authorList>
<person name="Viles J.H."/>
<person name="Patel S.U."/>
<person name="Mitchell J.B.O."/>
<person name="Moody C.M."/>
<person name="Justice D.E."/>
<person name="Uppenbrink J."/>
<person name="Doyle P.M."/>
<person name="Harris C.J."/>
<person name="Sadler P.J."/>
<person name="Thornton J.M."/>
</authorList>
<dbReference type="PubMed" id="9642075"/>
<dbReference type="DOI" id="10.1006/jmbi.1998.1764"/>
</citation>
<scope>STRUCTURE BY NMR OF 353-379</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2010" name="Nat. Genet." volume="42" first="1109" last="1112">
<title>A de novo paradigm for mental retardation.</title>
<authorList>
<person name="Vissers L.E."/>
<person name="de Ligt J."/>
<person name="Gilissen C."/>
<person name="Janssen I."/>
<person name="Steehouwer M."/>
<person name="de Vries P."/>
<person name="van Lier B."/>
<person name="Arts P."/>
<person name="Wieskamp N."/>
<person name="del Rosario M."/>
<person name="van Bon B.W."/>
<person name="Hoischen A."/>
<person name="de Vries B.B."/>
<person name="Brunner H.G."/>
<person name="Veltman J.A."/>
</authorList>
<dbReference type="PubMed" id="21076407"/>
<dbReference type="DOI" id="10.1038/ng.712"/>
</citation>
<scope>VARIANT GADEVS TYR-380</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2013" name="Nat. Commun." volume="4" first="2810" last="2810">
<title>Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1.</title>
<authorList>
<person name="Cao Y."/>
<person name="Gao Z."/>
<person name="Li L."/>
<person name="Jiang X."/>
<person name="Shan A."/>
<person name="Cai J."/>
<person name="Peng Y."/>
<person name="Li Y."/>
<person name="Jiang X."/>
<person name="Huang X."/>
<person name="Wang J."/>
<person name="Wei Q."/>
<person name="Qin G."/>
<person name="Zhao J."/>
<person name="Jin X."/>
<person name="Liu L."/>
<person name="Li Y."/>
<person name="Wang W."/>
<person name="Wang J."/>
<person name="Ning G."/>
</authorList>
<dbReference type="PubMed" id="24326773"/>
<dbReference type="DOI" id="10.1038/ncomms3810"/>
</citation>
<scope>VARIANT ARG-372</scope>
<scope>CHARACTERIZATION OF VARIANT ARG-372</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2015" name="Proc. Natl. Acad. Sci. U.S.A." volume="112" first="4062" last="4067">
<title>Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomas.</title>
<authorList>
<person name="Cromer M.K."/>
<person name="Choi M."/>
<person name="Nelson-Williams C."/>
<person name="Fonseca A.L."/>
<person name="Kunstman J.W."/>
<person name="Korah R.M."/>
<person name="Overton J.D."/>
<person name="Mane S."/>
<person name="Kenney B."/>
<person name="Malchoff C.D."/>
<person name="Stalberg P."/>
<person name="Akerstroem G."/>
<person name="Westin G."/>
<person name="Hellman P."/>
<person name="Carling T."/>
<person name="Bjoerklund P."/>
<person name="Lifton R.P."/>
</authorList>
<dbReference type="PubMed" id="25787250"/>
<dbReference type="DOI" id="10.1073/pnas.1503696112"/>
</citation>
<scope>VARIANT ARG-372</scope>
<scope>CHARACTERIZATION OF VARIANT ARG-372</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2017" name="Am. J. Hum. Genet." volume="100" first="907" last="925">
<title>YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction.</title>
<authorList>
<person name="Gabriele M."/>
<person name="Vulto-van Silfhout A.T."/>
<person name="Germain P.L."/>
<person name="Vitriolo A."/>
<person name="Kumar R."/>
<person name="Douglas E."/>
<person name="Haan E."/>
<person name="Kosaki K."/>
<person name="Takenouchi T."/>
<person name="Rauch A."/>
<person name="Steindl K."/>
<person name="Frengen E."/>
<person name="Misceo D."/>
<person name="Pedurupillay C.R.J."/>
<person name="Stromme P."/>
<person name="Rosenfeld J.A."/>
<person name="Shao Y."/>
<person name="Craigen W.J."/>
<person name="Schaaf C.P."/>
<person name="Rodriguez-Buritica D."/>
<person name="Farach L."/>
<person name="Friedman J."/>
<person name="Thulin P."/>
<person name="McLean S.D."/>
<person name="Nugent K.M."/>
<person name="Morton J."/>
<person name="Nicholl J."/>
<person name="Andrieux J."/>
<person name="Stray-Pedersen A."/>
<person name="Chambon P."/>
<person name="Patrier S."/>
<person name="Lynch S.A."/>
<person name="Kjaergaard S."/>
<person name="Toerring P.M."/>
<person name="Brasch-Andersen C."/>
<person name="Ronan A."/>
<person name="van Haeringen A."/>
<person name="Anderson P.J."/>
<person name="Powis Z."/>
<person name="Brunner H.G."/>
<person name="Pfundt R."/>
<person name="Schuurs-Hoeijmakers J.H.M."/>
<person name="van Bon B.W.M."/>
<person name="Lelieveld S."/>
<person name="Gilissen C."/>
<person name="Nillesen W.M."/>
<person name="Vissers L.E.L.M."/>
<person name="Gecz J."/>
<person name="Koolen D.A."/>
<person name="Testa G."/>
<person name="de Vries B.B.A."/>
</authorList>
<dbReference type="PubMed" id="28575647"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2017.05.006"/>
</citation>
<scope>VARIANTS GADEVS 179-LYS--GLN-414 DEL; TYR-320; GLN-339; 344-GLN--GLN-414 DEL; PRO-366; VAL-366; TYR-380 AND LYS-393 DEL</scope>
<scope>CHARACTERIZATION OF VARIANTS GADEVS PRO-366 AND TYR-380</scope>
<scope>FUNCTION</scope>
</reference>
<comment type="function">
<text evidence="18 26 27 28">Multifunctional transcription factor that exhibits positive and negative control on a large number of cellular and viral genes by binding to sites overlapping the transcription start site. Binds to the consensus sequence 5'-CCGCCATNTT-3'; some genes have been shown to contain a longer binding motif allowing enhanced binding; the initial CG dinucleotide can be methylated greatly reducing the binding affinity. The effect on transcription regulation is depending upon the context in which it binds and diverse mechanisms of action include direct activation or repression, indirect activation or repression via cofactor recruitment, or activation or repression by disruption of binding sites or conformational DNA changes. Its activity is regulated by transcription factors and cytoplasmic proteins that have been shown to abrogate or completely inhibit YY1-mediated activation or repression. For example, it acts as a repressor in absence of adenovirus E1A protein but as an activator in its presence. Acts synergistically with the SMAD1 and SMAD4 in bone morphogenetic protein (BMP)-mediated cardiac-specific gene expression (PubMed:15329343). Binds to SMAD binding elements (SBEs) (5'-GTCT/AGAC-3') within BMP response element (BMPRE) of cardiac activating regions. May play an important role in development and differentiation. Proposed to recruit the PRC2/EED-EZH2 complex to target genes that are transcriptional repressed. Involved in DNA repair. In vitro, binds to DNA recombination intermediate structures (Holliday junctions). Plays a role in regulating enhancer activation (PubMed:28575647).</text>
</comment>
<comment type="function">
<text evidence="19 20">Proposed core component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair; proposed to target the INO80 complex to YY1-responsive elements.</text>
</comment>
<comment type="subunit">
<text evidence="15 17 18 19 20 21 24 25 29">Interacts with YAF2 through the region encompassing the first and second zinc fingers (PubMed:9016636). Component of the chromatin remodeling INO80 complex; specifically part of a complex module associated with the DBINO domain of INO80 (PubMed:17721549, PubMed:18026119, PubMed:18922472, PubMed:21303910). Interacts with EED and EZH2; the interactions are indicative for an association with the PRC2/EED-EZH2 complex (PubMed:11158321). Interacts with SFMBT2 (PubMed:23385818). Found in a complex with SMAD1 and SMAD4 (PubMed:15329343). Found in a complex with YY1, SIN3A and HDAC1 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-355018">
<id>O96019</id>
<label>ACTL6A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-6925949">
<id>Q9BYJ1</id>
<label>ALOXE3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-743313">
<id>P49407</id>
<label>ARRB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-742887">
<id>Q8TAP6</id>
<label>CEP76</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-3867333">
<id>A8MQ03</id>
<label>CYSRT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-12260294">
<id>Q9NQ30</id>
<label>ESM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-701903">
<id>Q14192</id>
<label>FHL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-2548508">
<id>Q96IK5</id>
<label>GMCL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-1031632">
<id>P22301</id>
<label>IL10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-769345">
<id>Q9ULG1</id>
<label>INO80</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-11741292">
<id>Q9BYS1</id>
<label>KRTAP1-5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-10172150">
<id>P60370</id>
<label>KRTAP10-5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-10171774">
<id>P60410</id>
<label>KRTAP10-8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-10172052">
<id>P60411</id>
<label>KRTAP10-9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-10176379">
<id>P59991</id>
<label>KRTAP12-2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-11953334">
<id>P60328</id>
<label>KRTAP12-3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-11988175">
<id>Q9BYP8</id>
<label>KRTAP17-1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-14065470">
<id>Q9BYR9</id>
<label>KRTAP2-4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-10172511">
<id>Q9BYR5</id>
<label>KRTAP4-2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-11993254">
<id>Q9BYR2</id>
<label>KRTAP4-5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-10250562">
<id>Q6L8G9</id>
<label>KRTAP5-6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-1043191">
<id>Q9BYQ3</id>
<label>KRTAP9-3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-11958364">
<id>Q9BYQ0</id>
<label>KRTAP9-8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-12039345">
<id>Q9UBR4-2</id>
<label>LHX3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-2865388">
<id>Q969G2</id>
<label>LHX4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-724076">
<id>Q99750</id>
<label>MDFI</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-394644">
<id>Q9H944</id>
<label>MED20</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-742388">
<id>Q9H8W4</id>
<label>PLEKHF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-352053">
<id>P78527</id>
<label>PRKDC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-353675">
<id>Q9Y265</id>
<label>RUVBL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-352939">
<id>Q9Y230</id>
<label>RUVBL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-2462271">
<id>Q15428</id>
<label>SF3A2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-5235829">
<id>Q8IWZ5</id>
<label>TRIM42</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-11957238">
<id>Q2TAL6</id>
<label>VWC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-2340004">
<id>Q9HD64</id>
<label>XAGE1E</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-946122">
<id>Q9H869</id>
<label>YY1AP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-12150045">
<id>Q9H869-2</id>
<label>YY1AP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-18141506">
<id>Q49A12</id>
<label>ZNF85</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-7453955">
<id>Q8JSK4</id>
<label>E1A</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-929290">
<id>Q8CCI5</id>
<label>Rybp</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-765538">
<id>P25490</id>
</interactant>
<interactant intactId="EBI-6947456">
<id>P03259</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="20 25 30">Nucleus matrix</location>
</subcellularLocation>
<text>Associated with the nuclear matrix.</text>
</comment>
<comment type="PTM">
<text>Transiently poly-ADP-ribosylated by PARP1 upon DNA damage, with the effect of decreasing affinity of YY1 to its cognate DNA binding sites.</text>
</comment>
<comment type="PTM">
<text evidence="22">Ubiquitinated.</text>
</comment>
<comment type="disease" evidence="23 28">
<disease id="DI-05032">
<name>Gabriele-de Vries syndrome</name>
<acronym>GADEVS</acronym>
<description>An autosomal dominant neurodevelopmental disorder characterized by delayed psychomotor development and intellectual disability. Most patients have behavioral and feeding problems, movement abnormalities, mild distal skeletal anomalies, and dysmorphic facial features.</description>
<dbReference type="MIM" id="617557"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="31">Belongs to the YY transcription factor family.</text>
</comment>
<dbReference type="EMBL" id="M77698">
<property type="protein sequence ID" value="AAA59467.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M76541">
<property type="protein sequence ID" value="AAA59926.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z14077">
<property type="protein sequence ID" value="CAA78455.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC037308">
<property type="protein sequence ID" value="AAH37308.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC065366">
<property type="protein sequence ID" value="AAH65366.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS9957.1"/>
<dbReference type="PIR" id="A40350">
<property type="entry name" value="A40350"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003394.1">
<property type="nucleotide sequence ID" value="NM_003403.4"/>
</dbReference>
<dbReference type="PDB" id="1UBD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="C=291-414"/>
</dbReference>
<dbReference type="PDB" id="1ZNM">
<property type="method" value="NMR"/>
<property type="chains" value="A=352-379"/>
</dbReference>
<dbReference type="PDB" id="4C5I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.59"/>
<property type="chains" value="C=199-228"/>
</dbReference>
<dbReference type="PDBsum" id="1UBD"/>
<dbReference type="PDBsum" id="1ZNM"/>
<dbReference type="PDBsum" id="4C5I"/>
<dbReference type="SMR" id="P25490"/>
<dbReference type="BioGRID" id="113360">
<property type="interactions" value="176"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-846">
<property type="entry name" value="INO80 chromatin remodeling complex"/>
</dbReference>
<dbReference type="CORUM" id="P25490"/>
<dbReference type="DIP" id="DIP-150N"/>
<dbReference type="IntAct" id="P25490">
<property type="interactions" value="108"/>
</dbReference>
<dbReference type="MINT" id="P25490"/>
<dbReference type="STRING" id="9606.ENSP00000262238"/>
<dbReference type="iPTMnet" id="P25490"/>
<dbReference type="PhosphoSitePlus" id="P25490"/>
<dbReference type="BioMuta" id="YY1"/>
<dbReference type="DMDM" id="3915889"/>
<dbReference type="EPD" id="P25490"/>
<dbReference type="jPOST" id="P25490"/>
<dbReference type="MassIVE" id="P25490"/>
<dbReference type="MaxQB" id="P25490"/>
<dbReference type="PaxDb" id="P25490"/>
<dbReference type="PeptideAtlas" id="P25490"/>
<dbReference type="PRIDE" id="P25490"/>
<dbReference type="ProteomicsDB" id="54279"/>
<dbReference type="Antibodypedia" id="9">
<property type="antibodies" value="571 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="7528"/>
<dbReference type="Ensembl" id="ENST00000262238">
<property type="protein sequence ID" value="ENSP00000262238"/>
<property type="gene ID" value="ENSG00000100811"/>
</dbReference>
<dbReference type="GeneID" id="7528"/>
<dbReference type="KEGG" id="hsa:7528"/>
<dbReference type="UCSC" id="uc001ygy.3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7528"/>
<dbReference type="DisGeNET" id="7528"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000100811.10"/>
<dbReference type="GeneCards" id="YY1"/>
<dbReference type="HGNC" id="HGNC:12856">
<property type="gene designation" value="YY1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000100811">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="YY1"/>
<dbReference type="MIM" id="600013">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="617557">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P25490"/>
<dbReference type="OpenTargets" id="ENSG00000100811"/>
<dbReference type="Orphanet" id="506358">
<property type="disease" value="Gabriele-de Vries syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA37445"/>
<dbReference type="eggNOG" id="KOG1721">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000154763"/>
<dbReference type="InParanoid" id="P25490"/>
<dbReference type="KO" id="K09201"/>
<dbReference type="OMA" id="MWASDDN"/>
<dbReference type="OrthoDB" id="1318335at2759"/>
<dbReference type="PhylomeDB" id="P25490"/>
<dbReference type="TreeFam" id="TF106493"/>
<dbReference type="PathwayCommons" id="P25490"/>
<dbReference type="Reactome" id="R-HSA-5617472">
<property type="pathway name" value="Activation of anterior HOX genes in hindbrain development during early embryogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689603">
<property type="pathway name" value="UCH proteinases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5696394">
<property type="pathway name" value="DNA Damage Recognition in GG-NER"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866910">
<property type="pathway name" value="TFAP2 (AP-2) family regulates transcription of growth factors and their receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9018519">
<property type="pathway name" value="Estrogen-dependent gene expression"/>
</dbReference>
<dbReference type="SignaLink" id="P25490"/>
<dbReference type="SIGNOR" id="P25490"/>
<dbReference type="BioGRID-ORCS" id="7528">
<property type="hits" value="579 hits in 907 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="YY1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P25490"/>
<dbReference type="GeneWiki" id="YY1"/>
<dbReference type="GenomeRNAi" id="7528"/>
<dbReference type="Pharos" id="P25490">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P25490"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 14"/>
</dbReference>
<dbReference type="RNAct" id="P25490">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000100811">
<property type="expression patterns" value="Expressed in amniotic fluid and 252 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P25490">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P25490">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031011">
<property type="term" value="C:Ino80 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016363">
<property type="term" value="C:nuclear matrix"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031519">
<property type="term" value="C:PcG protein complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005667">
<property type="term" value="C:transcription regulator complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000987">
<property type="term" value="F:cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0001217">
<property type="term" value="F:DNA-binding transcription repressor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001227">
<property type="term" value="F:DNA-binding transcription repressor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000400">
<property type="term" value="F:four-way junction DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043565">
<property type="term" value="F:sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1990837">
<property type="term" value="F:sequence-specific double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046332">
<property type="term" value="F:SMAD binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0009952">
<property type="term" value="P:anterior/posterior pattern specification"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048593">
<property type="term" value="P:camera-type eye morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071347">
<property type="term" value="P:cellular response to interleukin-1"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034644">
<property type="term" value="P:cellular response to UV"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051276">
<property type="term" value="P:chromosome organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000724">
<property type="term" value="P:double-strand break repair via homologous recombination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061052">
<property type="term" value="P:negative regulation of cell growth involved in cardiac muscle cell development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0032688">
<property type="term" value="P:negative regulation of interferon-beta production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902894">
<property type="term" value="P:negative regulation of pri-miRNA transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034696">
<property type="term" value="P:response to prostaglandin F"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010225">
<property type="term" value="P:response to UV-C"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006403">
<property type="term" value="P:RNA localization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007283">
<property type="term" value="P:spermatogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="IDEAL" id="IID00234"/>
<dbReference type="InterPro" id="IPR017114">
<property type="entry name" value="YY1-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR036236">
<property type="entry name" value="Znf_C2H2_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013087">
<property type="entry name" value="Znf_C2H2_type"/>
</dbReference>
<dbReference type="Pfam" id="PF00096">
<property type="entry name" value="zf-C2H2"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037113">
<property type="entry name" value="TF_Yin_yang"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00355">
<property type="entry name" value="ZnF_C2H2"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57667">
<property type="entry name" value="SSF57667"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS00028">
<property type="entry name" value="ZINC_FINGER_C2H2_1"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS50157">
<property type="entry name" value="ZINC_FINGER_C2H2_2"/>
<property type="match status" value="4"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0013">ADP-ribosylation</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0233">DNA recombination</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0744">Spermatogenesis</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Transcriptional repressor protein YY1" id="PRO_0000047190">
<location>
<begin position="1"/>
<end position="414"/>
</location>
</feature>
<feature type="zinc finger region" description="C2H2-type 1" evidence="16">
<location>
<begin position="296"/>
<end position="320"/>
</location>
</feature>
<feature type="zinc finger region" description="C2H2-type 2" evidence="16">
<location>
<begin position="325"/>
<end position="347"/>
</location>
</feature>
<feature type="zinc finger region" description="C2H2-type 3" evidence="16">
<location>
<begin position="353"/>
<end position="377"/>
</location>
</feature>
<feature type="zinc finger region" description="C2H2-type 4" evidence="16">
<location>
<begin position="383"/>
<end position="407"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with the SMAD1/SMAD4 complex">
<location>
<begin position="1"/>
<end position="170"/>
</location>
</feature>
<feature type="region of interest" description="Involved in nuclear matrix association">
<location>
<begin position="257"/>
<end position="341"/>
</location>
</feature>
<feature type="region of interest" description="Binding to DNA">
<location>
<begin position="295"/>
<end position="414"/>
</location>
</feature>
<feature type="region of interest" description="Involved in repression of activated transcription">
<location>
<begin position="333"/>
<end position="371"/>
</location>
</feature>
<feature type="region of interest" description="Involved in masking transactivation domain">
<location>
<begin position="371"/>
<end position="397"/>
</location>
</feature>
<feature type="compositionally biased region" description="Asp/Glu-rich (acidic)">
<location>
<begin position="43"/>
<end position="53"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gly-rich">
<location>
<begin position="54"/>
<end position="69"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-His">
<location>
<begin position="70"/>
<end position="80"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gly/Ser-rich">
<location>
<begin position="159"/>
<end position="170"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1">
<location>
<position position="298"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1">
<location>
<position position="303"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1">
<location>
<position position="316"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1">
<location>
<position position="320"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2">
<location>
<position position="327"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2">
<location>
<position position="330"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2">
<location>
<position position="343"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2">
<location>
<position position="347"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3">
<location>
<position position="355"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3">
<location>
<position position="360"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3">
<location>
<position position="373"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3">
<location>
<position position="377"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 4">
<location>
<position position="385"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 4">
<location>
<position position="390"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 4">
<location>
<position position="403"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 4">
<location>
<position position="407"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 7 8 9 10">
<location>
<position position="118"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="187"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5 6 9 10">
<location>
<position position="247"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="4">
<location>
<position position="378"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14">
<location>
<position position="182"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="11 14">
<location>
<position position="183"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14">
<location>
<position position="208"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14">
<location>
<position position="230"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="11 14">
<location>
<position position="286"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="11 12 13 14">
<location>
<position position="288"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14">
<location>
<position position="409"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14">
<location>
<position position="411"/>
</location>
</feature>
<feature type="sequence variant" description="In GADEVS." id="VAR_079202" evidence="28">
<location>
<begin position="179"/>
<end position="414"/>
</location>
</feature>
<feature type="sequence variant" description="In GADEVS; unknown pathological significance." id="VAR_079203" evidence="28">
<original>H</original>
<variation>Y</variation>
<location>
<position position="320"/>
</location>
</feature>
<feature type="sequence variant" description="In GADEVS; unknown pathological significance; dbSNP:rs1555370868." id="VAR_079204" evidence="28">
<original>K</original>
<variation>Q</variation>
<location>
<position position="339"/>
</location>
</feature>
<feature type="sequence variant" description="In GADEVS." id="VAR_079205" evidence="28">
<location>
<begin position="344"/>
<end position="414"/>
</location>
</feature>
<feature type="sequence variant" description="In GADEVS; reduced DNA-binding; reduced transcription regulator activity; dbSNP:rs1131692163." id="VAR_079206" evidence="28">
<original>L</original>
<variation>P</variation>
<location>
<position position="366"/>
</location>
</feature>
<feature type="sequence variant" description="In GADEVS; unknown pathological significance; dbSNP:rs1131692044." id="VAR_079207" evidence="28">
<original>L</original>
<variation>V</variation>
<location>
<position position="366"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with late onset insulinomas; alters DNA-binding motif; increases transactivation activity; produces a constitutive activation of cAMP and Ca2+ signaling pathways involved in insulin secretion; dbSNP:rs386834266." id="VAR_074172" evidence="26 27">
<original>T</original>
<variation>R</variation>
<location>
<position position="372"/>
</location>
</feature>
<feature type="sequence variant" description="In GADEVS; reduced DNA-binding; reduced transcription regulator activity; dbSNP:rs1131692043." id="VAR_065086" evidence="23 28">
<original>D</original>
<variation>Y</variation>
<location>
<position position="380"/>
</location>
</feature>
<feature type="sequence variant" description="In GADEVS; unknown pathological significance." id="VAR_079208" evidence="28">
<location>
<position position="393"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA59926." ref="2" evidence="31">
<original>H</original>
<variation>R</variation>
<location>
<position position="65"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA59467." ref="1" evidence="31">
<original>G</original>
<variation>R</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="207"/>
<end position="211"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="220"/>
<end position="224"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="306"/>
<end position="309"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="310"/>
<end position="317"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="318"/>
<end position="320"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="328"/>
<end position="330"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="333"/>
<end position="336"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="337"/>
<end position="343"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="344"/>
<end position="346"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="358"/>
<end position="360"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="363"/>
<end position="365"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="367"/>
<end position="378"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="397"/>
<end position="400"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="401"/>
<end position="407"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1UBD"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1ZNM"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4C5I"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q00899"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00042"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11158321"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15329343"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17721549"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18026119"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18922472"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20596523"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21076407"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21303910"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23385818"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24326773"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25787250"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28575647"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9016636"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9493912"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000305"/>
<sequence length="414" mass="44713" checksum="058C05A0AD2D04E6" modified="1998-12-15" version="2">MASGDTLYIATDGSEMPAEIVELHEIEVETIPVETIETTVVGEEEEEDDDDEDGGGGDHGGGGGHGHAGHHHHHHHHHHHPPMIALQPLVTDDPTQVHHHQEVILVQTREEVVGGDDSDGLRAEDGFEDQILIPVPAPAGGDDDYIEQTLVTVAAAGKSGGGGSSSSGGGRVKKGGGKKSGKKSYLSGGAGAAGGGGADPGNKKWEQKQVQIKTLEGEFSVTMWSSDEKKDIDHETVVEEQIIGENSPPDYSEYMTGKKLPPGGIPGIDLSDPKQLAEFARMKPRKIKEDDAPRTIACPHKGCTKMFRDNSAMRKHLHTHGPRVHVCAECGKAFVESSKLKRHQLVHTGEKPFQCTFEGCGKRFSLDFNLRTHVRIHTGDRPYVCPFDGCNKKFAQSTNLKSHILTHAKAKNNQ</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

